RDS Completes Seed Funding Round Welcoming Capital Grand Est as Investor
We are thrilled to announce the addition of Capital Grand Est to our pool of investors, which completes our €13M round of seed funding! This latest backing is another big milestone in our journey to advance patient pathways. RDS is now all focused on the last steps before commercialization. Stay tuned!
To read the full release, please click here.